Literature DB >> 20581061

Endothelial-specific overexpression of caveolin-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.

Carlos Fernández-Hernando1, Jun Yu, Alberto Dávalos, Jay Prendergast, William C Sessa.   

Abstract

Caveolin-1 (Cav-1) is the major structural protein essential to the formation of the caveolae in endothelial cells. Genetic ablation of Cav-1 on an apolipoprotein E knockout background inhibits the progression of atherosclerosis, whereas re-expression of Cav-1 in the endothelium promotes lesion expansion. Although Cav-1-null mice are useful to delineate the importance of caveolae in atherosclerosis, there are additional problems that are difficult to dissect because loss of Cav-1 abolishes both the caveolae organelle as well as the Cav-1-mediated signaling pathways. To study how Cav-1 influences the progression of atherosclerosis in mice with caveolae, we generated a transgenic mouse that overexpresses Cav-1 in the endothelial cells in an apolipoprotein E-deficient background. We found that endothelial-specific overexpression of Cav-1 enhanced the progression of atherosclerosis in mice. Mechanistically, overexpression of Cav-1 reduced endothelial cell proliferation, migration, and nitric oxide production in vitro and increased expression of vascular cell adhesion molecule-1 in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581061      PMCID: PMC2913373          DOI: 10.2353/ajpath.2010.091287

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.

Authors:  M Drab; P Verkade; M Elger; M Kasper; M Lohn; B Lauterbach; J Menne; C Lindschau; F Mende; F C Luft; A Schedl; H Haller; T V Kurzchalia
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

Review 2.  Multiple functions of caveolin-1.

Authors:  Pingsheng Liu; Michael Rudick; Richard G W Anderson
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

3.  Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release.

Authors:  David Fulton; Roger Babbitt; Stefan Zoellner; Jason Fontana; Lisette Acevedo; Timothy J McCabe; Yasuko Iwakiri; William C Sessa
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

Review 4.  eNOS at a glance.

Authors:  William C Sessa
Journal:  J Cell Sci       Date:  2004-05-15       Impact factor: 5.285

5.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.

Authors:  B Razani; J A Engelman; X B Wang; W Schubert; X L Zhang; C B Marks; F Macaluso; R G Russell; M Li; R G Pestell; D Di Vizio; H Hou; B Kneitz; G Lagaud; G J Christ; W Edelmann; M P Lisanti
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

6.  Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue.

Authors:  Alex W Cohen; Babak Razani; Xiao Bo Wang; Terry P Combs; Terence M Williams; Philipp E Scherer; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2003-03-26       Impact factor: 4.249

7.  Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.

Authors:  William Schubert; Philippe G Frank; Scott E Woodman; Hideyuki Hyogo; David E Cohen; Chi-Wing Chow; Michael P Lisanti
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

8.  Genetic ablation of caveolin-1 confers protection against atherosclerosis.

Authors:  Philippe G Frank; Hyangkyu Lee; David S Park; Narendra N Tandon; Phillip E Scherer; Michael P Lisanti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-16       Impact factor: 8.311

9.  Caveolin-1 deficiency stimulates neointima formation during vascular injury.

Authors:  Ghada S Hassan; Jean-François Jasmin; William Schubert; Philippe G Frank; Michael P Lisanti
Journal:  Biochemistry       Date:  2004-07-06       Impact factor: 3.162

Review 10.  Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia.

Authors:  Philippe G Frank; Michael P Lisanti
Journal:  Curr Opin Lipidol       Date:  2004-10       Impact factor: 4.776

View more
  46 in total

1.  Endothelial caveolae and caveolin-1 as key regulators of atherosclerosis.

Authors:  Philippe G Frank
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

2.  Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression.

Authors:  Margaret E McCormick; Reema Goel; David Fulton; Stefanie Oess; Debra Newman; Ellie Tzima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-23       Impact factor: 8.311

3.  Genetic variants on chromosomes 7p31 and 12p12 are associated with abnormal atrial electrical activation in patients with early-onset lone atrial fibrillation.

Authors:  Mariam B Seifert; Morten S Olesen; Ingrid E Christophersen; Jonas B Nielsen; Jonas Carlson; Fredrik Holmqvist; Arnljot Tveit; Stig Haunsø; Jesper H Svendsen; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-01       Impact factor: 1.468

4.  Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation.

Authors:  Cristina M Ramírez; Xinbo Zhang; Chirosree Bandyopadhyay; Noemi Rotllan; Michael G Sugiyama; Binod Aryal; Xinran Liu; Shun He; Jan R Kraehling; Victoria Ulrich; Chin Sheng Lin; Heino Velazquez; Miguel A Lasunción; Guangxin Li; Yajaira Suárez; George Tellides; Filip K Swirski; Warren L Lee; Martin A Schwartz; William C Sessa; Carlos Fernández-Hernando
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

5.  Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.

Authors:  Franco Capozza; Casey Trimmer; Remedios Castello-Cros; Sanjay Katiyar; Diana Whitaker-Menezes; Antonia Follenzi; Marco Crosariol; Gemma Llaverias; Federica Sotgia; Richard G Pestell; Michael P Lisanti
Journal:  Cancer Res       Date:  2012-03-06       Impact factor: 12.701

6.  AMP-Activated Protein Kinase and Sirtuin 1 Coregulation of Cortactin Contributes to Endothelial Function.

Authors:  Tzu-Pin Shentu; Ming He; Xiaoli Sun; Jianlin Zhang; Fan Zhang; Brendan Gongol; Traci L Marin; Jiao Zhang; Liang Wen; Yinsheng Wang; Gregory G Geary; Yi Zhu; David A Johnson; John Y-J Shyy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

7.  Caveolin-1 scaffolding domain promotes leukocyte adhesion by reduced basal endothelial nitric oxide-mediated ICAM-1 phosphorylation in rat mesenteric venules.

Authors:  Sulei Xu; Xueping Zhou; Dong Yuan; Yanchun Xu; Pingnian He
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

8.  15-lipoxygenase-mediated modification of HDL3 impairs eNOS activation in human endothelial cells.

Authors:  Lucia Cutuli; Angela Pirillo; Patrizia Uboldi; Hartmut Kuehn; Alberico L Catapano
Journal:  Lipids       Date:  2014-02-26       Impact factor: 1.880

9.  Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss.

Authors:  Stephanie J Loomis; Jae H Kang; Robert N Weinreb; Brian L Yaspan; Jessica N Cooke Bailey; Douglas Gaasterland; Terry Gaasterland; Richard K Lee; Paul R Lichter; Donald L Budenz; Yutao Liu; Tony Realini; David S Friedman; Catherine A McCarty; Sayoko E Moroi; Lana Olson; Joel S Schuman; Kuldev Singh; Douglas Vollrath; Gadi Wollstein; Donald J Zack; Murray Brilliant; Arthur J Sit; William G Christen; John Fingert; Peter Kraft; Kang Zhang; R Rand Allingham; Margaret A Pericak-Vance; Julia E Richards; Michael A Hauser; Jonathan L Haines; Louis R Pasquale; Janey L Wiggs
Journal:  Ophthalmology       Date:  2013-10-25       Impact factor: 12.079

10.  A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis.

Authors:  Susan M Armstrong; Michael G Sugiyama; Karen Y Y Fung; Yizhuo Gao; Changsen Wang; Andrew S Levy; Paymon Azizi; Mark Roufaiel; Su-Ning Zhu; Dante Neculai; Charles Yin; Steffen-Sebastian Bolz; Nabil G Seidah; Myron I Cybulsky; Bryan Heit; Warren L Lee
Journal:  Cardiovasc Res       Date:  2015-09-02       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.